<?xml version="1.0" encoding="UTF-8"?>
<p>Plant-derived compounds as an alternative therapy for microbial infections have been established to be one of the most auspicious sources to develop new therapeutic alternatives. During the last decades, an accumulating interest in the screening of plant-derived products has been appreciated considering their availability and safety when compared with synthetic compounds [
 <xref rid="B1-molecules-25-05514" ref-type="bibr">1</xref>]. Among these, essential oils (EOs) constitute an important source of biologically active compounds, which are complex mixtures mostly constituted of secondary metabolites. More than 3000 EOs have been identified or commercialized, due to their frequent use in cosmetics and flavors, as well as in the food industries, like spices, or to prepare beverages. They are also widely known for their use in traditional medicine as antibacterial, insecticidal, fungicidal, nematicidal, herbicidal, antioxidant, and anti-inflammatory agents [
 <xref rid="B2-molecules-25-05514" ref-type="bibr">2</xref>,
 <xref rid="B3-molecules-25-05514" ref-type="bibr">3</xref>].
</p>
